ACBI-1 is a PROTAC technology-based BAF ATPase subunit SMARCA2 and SMARCA4 degradant, is also a PBAF member PBRM1 degradant, and can effectively inhibit the proliferation of tumor cells (136). Here, SMARCA2 is linked to neoplasm.